Eric Ho Articles
Last 50 articles...
- Insurance Ups and Downs for Diabetes Drugs in 2014
- Zogenix, Zohydro ER Face Familiar Post-Approval Hurdles
- Payor Trouble for Advair, GlaxoSmithKline Drugs in 2014
- Rite Aid, Walgreen, and CVS: Can In-Store Care Push Pharmacy Stocks Forward?
- The Weight Loss Drug Company Investors Need to Watch Out For
- CVS Caremark's Big Thanksgiving Purchase: The Coram Buyout
- The Good News, Bad News for Belviq: …Now the Good News
- The Good News, Bad News for Belviq: Bad News First…
- Eteplirsen in Question: Hope for Sarepta
- Pain and Abuse: The Challenge in Bringing Zohydro to Market
- Walgreen and the Biggest Biotech Startup You've Never Heard Of
- The Clinical Lowdown: Keryx and Zerenex
- MannKind Bulls Should Prepare for the Long Haul